Yüklüyor......
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
BACKGROUND: Tumour necrosis factor (TNF)‐alpha inhibitors are beneficial for the treatment of rheumatoid arthritis (RA) for reducing the risk of joint damage, improving physical function and improving the quality of life. This review is an update of the 2014 Cochrane Review of the treatment of RA wi...
Kaydedildi:
| Yayımlandı: | Cochrane Database Syst Rev |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Ltd
2017
|
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483724/ https://ncbi.nlm.nih.gov/pubmed/28884785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007649.pub4 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|